Nephros, Inc. (NEPH)

Market Cap	43.77M -0.5%
Revenue (ttm)	20.72M +24.2%
Net Income	1.74M +30.8%
EPS	0.16 +34.3%
Shares Out	10.86M
PE Ratio	25.18
Forward PE	21.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,446
Open	4.220
Previous Close	4.230
Day's Range	4.000 - 4.370
52-Week Range	2.663 - 6.420
Beta	1.56
Analysts	Buy
Price Target	6.25 (+55.09%)
Est. Earnings	Nov 5, 2026

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 21, 2004
• Employees: 36
• Stock Exchange: NASDAQ
• Ticker Symbol: NEPH
• Website: https://www.nephros.com

Financial Performance

In 2025, Nephros's revenue was $18.79 million, an increase of 32.67% compared to the previous year's $14.16 million. Earnings were $1.19 million, an increase of 1513.51%.

Analyst Summary

According to 3 analysts, the average rating for NEPH stock is "Buy." The 12-month stock price target is $6.25, which is an increase of 55.09% from the latest price.

Price Target

$6.25

(55.09% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Sep 29, 2026

Data Sources Report a data error